Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

IRX 2

Known as: IRX-2 
A cell-free mixture comprised of a variety of naturally-derived cytokines obtained from normal, unrelated donor lymphocytes with potential… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Twenty-seven subjects with squamous cell cancer of the head and neck received the neoadjuvant IRX-2 immunotherapy regimen prior… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2011
2011
OBJECTIVES Head and neck squamous cell carcinoma (HNSCC) is associated with profound defects in cellular immunity. IRX-2, a… Expand
Is this relevant?
2010
2010
ObjectivesIRX-2 is a novel immunotherapeutic containing physiologic quantities of several cytokines which protects human T… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2010
2010
Therapeutic cancer vaccines are attractive due to the prospect of specificity and their lack of toxicity; however, their clinical… Expand
Is this relevant?
2009
2009
IRX-2 is a cytokine-based biologic agent that has the potential to enhance antitumor immune responses. We investigated whether… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2007
2007
IRX-2 is a uniform, well-defined set of natural cytokines currently in Phase II clinical trials for squamous cell carcinoma of… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2003
2003
OBJECTIVE To determine if lymph nodes (LN) of patients receiving IRX-2 immunotherapy reflect changes in histology. SETTING… Expand
Is this relevant?
2003
2003
A Phase II trial in 42 patients with squamous cell cancer of the head and neck (H and NSCC) was performed using a combination… Expand
Is this relevant?
1999
1999
Abstract In the mouse mammary gland, homeobox gene expression patterns suggest roles in development and neoplasia. In the human… Expand
Is this relevant?
1998
1998
OBJECTIVE To induce tumor regression with immunotherapy and to characterize the histology. SETTING National Institute of… Expand
Is this relevant?